Class II recall: SUN PHARMACEUTICAL INDUSTRIES INC: Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by:
Sun Pharmaceutical Industries Inc has issued a Class II recall for Carbamazepine Tablets, USP, 200mg, in 1000-count bottles, NDC 51672-4005-3, manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals USA, Inc. The recall was initiated due to CGMP deviations, specifically black spots on tablets caused by burnt excipient during the manufacturing process.
Most relevant for: Patients prescribed carbamazepine 200mg tablets from this specific lot and pharmacies or providers managing their supply.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More neurology updates
- Intensive BP Lowering Benefits Deep but Not Lobar HemorrhageNov 10, 2026
- Earlier Blood Biomarker Disclosure Boosts Diagnostic Certainty in Memory ClinicOct 5, 2026
- Iatrogenic cerebral amyloid angiopathy linked to high recurrent hemorrhage riskOct 27, 2026
- Study identifies clinical risk factors for chemotherapy-induced nerve toxicityOct 27, 2026
- Cervical cord atrophy in MS exceeds normal age-related declineOct 27, 2026